Harvard Bioscience
HBIO
79 hedge funds and large institutions have $116M invested in Harvard Bioscience in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 10 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
6% more capital invested
Capital invested by funds: $109M → $116M (+$7.01M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less funds holding
Funds holding: 80 → 79 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3.96M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$3.76M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.45M |
| 4 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$1.39M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$805K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$5.15M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.64M |
| 3 |
VDBMI
Van Den Berg Management I
Austin,
Texas
|
-$1.43M |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$917K |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$510K |
HBIO Hedge Fund Activity: Q1 2015 in Review
79 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q1 2015, worth a combined $116M — up 6.4% from $109M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of HBIO and 9 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 28 added.
The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $3.96M. The largest seller was Hussman Strategic Advisors, exiting entirely with an estimated $5.15M sold.
- 79 institutional investors held Harvard Bioscience (HBIO) as of Q1 2015, down from 80 in Q4 2014.
- Funds reported $116M of Harvard Bioscience stock for Q1 2015, up 6.4% quarter-over-quarter.
- 9 funds opened new Harvard Bioscience positions in Q1 2015 and 10 closed out, a net change of -1 holder.
- The largest Harvard Bioscience buyer in Q1 2015 was Polar Asset Management Partners, an estimated $3.96M added.
- The largest Harvard Bioscience seller in Q1 2015 was Hussman Strategic Advisors, an estimated $5.15M sold.
Based on aggregated 13F filings for Q1 2015.